These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. High prevalence of small LDL particles in non-insulin-dependent diabetic patients with nephropathy. Hirano T; Naito H; Kurokawa M; Ebara T; Nagano S; Adachi M; Yoshino G Atherosclerosis; 1996 Jun; 123(1-2):57-72. PubMed ID: 8782837 [TBL] [Abstract][Full Text] [Related]
4. Plasma angiotensin II, renin activity and serum angiotensin-converting enzyme activity in non-insulin dependent diabetes mellitus patients with diabetic nephropathy. Nicola W; Sidhom G; El Khyat Z; Ibrahim S; Salah A; El Sayed A Endocr J; 2001 Feb; 48(1):25-31. PubMed ID: 11403100 [TBL] [Abstract][Full Text] [Related]
5. Lipoprotein(a) in type 1 diabetic patients with renal disease. Groop PH; Viberti GC; Elliott TG; Friedman R; Mackie A; Ehnholm C; Jauhiainen M; Taskinen MR Diabet Med; 1994 Dec; 11(10):961-7. PubMed ID: 7895461 [TBL] [Abstract][Full Text] [Related]
6. [Alterations of Lp (a) lipoprotein in patients with chronic renal failure treated by continuous ambulatory peritoneal dialysis]. Takegoshi T; Kitoh C; Shimada T; Kawai K; Yamazaki Y; Mabuchi H Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):757-63. PubMed ID: 8377289 [TBL] [Abstract][Full Text] [Related]
7. Serum and urinary type IV collagen concentrations in the assessment of diabetic microangiopathy. Banu N; Hara H; Egusa G; Yamakido M Hiroshima J Med Sci; 1994 Dec; 43(4):123-33. PubMed ID: 7883578 [TBL] [Abstract][Full Text] [Related]
8. Serum lipoprotein(a) levels and diabetic nephropathy among Japanese patients with type 2 diabetes mellitus. Senba H; Furukawa S; Sakai T; Niiya T; Miyake T; Yamamoto S; Ueda T; Torisu M; Minami H; Miyaoka H; Onji M; Tanaka K; Matsuura B; Tanigawa T; Hiasa Y; Miyake Y J Diabetes Complications; 2016 Jul; 30(5):923-7. PubMed ID: 26947887 [TBL] [Abstract][Full Text] [Related]
10. Prospective study of lipoprotein(a) as a risk factor for deteriorating renal function in type 2 diabetic patients with overt proteinuria. Song KH; Ko SH; Kim HW; Ahn YB; Lee JM; Son HS; Yoon KH; Cha BY; Lee KW; Son HY Diabetes Care; 2005 Jul; 28(7):1718-23. PubMed ID: 15983325 [TBL] [Abstract][Full Text] [Related]
11. Lipoprotein(a) in patients with the nephrotic syndrome: influence of immunosuppression and proteinuria. Wanner C; Bartens W; Nauck M; Zäuner I; Greiber S; Schollmeyer P Miner Electrolyte Metab; 1996; 22(1-3):26-30. PubMed ID: 8676820 [TBL] [Abstract][Full Text] [Related]
12. Lipoprotein (a) concentration and apolipoprotein (a) phenotype in subjects with type 2 diabetes mellitus. Shi H; Fang J; Yang X; Shen Z; Zhu X Chin Med J (Engl); 1998 Nov; 111(11):1013-7. PubMed ID: 11189206 [TBL] [Abstract][Full Text] [Related]
13. Lack of relationship between Lp(a) particle levels and albumin excretion rate in type 1 diabetic patients. Guerci B; Igau B; Ziegler O; Crea T; Fruchart JC; Drouin P; Fievet C Diabete Metab; 1994; 20(6):526-31. PubMed ID: 7713275 [TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein(a) phenotypes and lipoprotein(a) concentrations in patients with renal failure. Milionis HJ; Elisaf MS; Tselepis A; Bairaktari E; Karabina SA; Siamopoulos KC Am J Kidney Dis; 1999 Jun; 33(6):1100-6. PubMed ID: 10352198 [TBL] [Abstract][Full Text] [Related]
15. Urinary excretion of apolipoprotein(a) fragments in type 1 diabetes mellitus patients. Clodi M; Oberbauer R; Bodlaj G; Hofmann J; Maurer G; Kostner K Metabolism; 1999 Mar; 48(3):369-72. PubMed ID: 10094115 [TBL] [Abstract][Full Text] [Related]
16. Increased plasma osteoprotegerin concentrations in Type 1 diabetes with albuminuria. Wang ST; Xu JM; Wang M; Chen FL; Ding G Clin Nephrol; 2013 Mar; 79(3):192-8. PubMed ID: 23073066 [TBL] [Abstract][Full Text] [Related]
17. Lipoprotein(a) in diabetes mellitus. Ritter MM; Loscar M; Richter WO; Schwandt P Clin Chim Acta; 1993 Jan; 214(1):45-54. PubMed ID: 8453777 [TBL] [Abstract][Full Text] [Related]
18. Impact of markedly elevated serum lipoprotein(a) levels (> or = 100 mg/dL) on the risk of coronary heart disease. Murase T; Okubo M; Amemiya-Kudo M; Hiraga T; Oka J; Shimada M; Igarashi T Metabolism; 2007 Sep; 56(9):1187-91. PubMed ID: 17697860 [TBL] [Abstract][Full Text] [Related]
19. Influence of endogenous and environmental factors on variations of serum lipoprotein (a) concentrations in a large population of insulin-treated diabetic patients. Durlach V; Gillery P; Bertin E; Grulet H; Gross A; Leutenegger M Diabetes Metab; 1998 Apr; 24(2):124-30. PubMed ID: 9592636 [TBL] [Abstract][Full Text] [Related]
20. The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy. Shimoike T; Inoguchi T; Umeda F; Nawata H; Kawano K; Ochi H Metabolism; 2000 Aug; 49(8):1030-5. PubMed ID: 10954022 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]